43 articles
Bishwanath Prasad Radhey Shyam vs Hindustan Metal Industries established the standard for inventive step and novelty in Indian patent law. The Supreme Court's reasoning remains central to assessing…
Section 3(d) of the Indian Patents Act limits patentability for new forms or uses of known substances unless enhanced efficacy is proven. The Novartis case illustrates how courts…
The Indian Patent Office often raises morality objections to sexual inventions, particularly in the context of devices and aids. This post analyses such objections, the legal framework under…
This abridged Novartis case by Dr. Kalyan C. Kankanala explains the patentability requirements under Section 3(d) of Indian patent law. It provides a structured analysis of the legal…
This presentation is part of the ‘Patent Law and Practice Program’ being taught by BananaIP Team at UPES School of Law to B.tech-LLB Students. This presentation is titled…
The Strategic Inventor Seminar by BananaIP Counsels provided corporate inventors with practical insights into patentability and infringement risks. Interactive sessions and expert guidance made it a valuable platform…
BananaIP’s inventor program, led by Dr Kalyan Kankanala, focused on practical aspects of patentability and invention assessment. Participants engaged in interactive exercises and gained valuable insights into patent…
This article examines cow slaughter within the framework of Indian patent law, addressing moral and legal issues surrounding patentability. It discusses relevant patent applications and the influence of…
This post provides an analytical overview of Indian patent cases, patentability standards, and litigation trends, supported by detailed statistics and key court decisions. It also examines patent licensing…
The following presentation titled ‘Pharma Patents and Drug Prices’ was delivered by Dr. Kalyan C. Kankanala (Managing Partner, BananaIP Counsels, Bangalore) on 5th January, 2016 at the conference…